The role of cytochrome c oxidase subunit Va in non-small cell lung carcinoma cells: Association with migration, invasion and prediction of distant metastasis

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Chen, Wen Liang ^a,b   Kuo, Kuang Tai ^b,d   Chou, Teh Ying ^c,d   Chen, Chien Lung ^b   Wang, Chih Hao ^d   Wei, Yau Huei ^d   Wang, Liang Shun ^b,e  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Cytochrome C oxidase subunit Va; Invasion; Migration; Non small cell lung cancer

Indexed keywords

CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE SUBUNIT VA; GALECTIN 1; GALECTIN 3; GELATIN; GELATINASE A; GELATINASE B; GLUCOSE REGULATED PROTEIN 78; GLUCURONOSYLTRANSFERASE; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 8; MATRIGEL; ONCOPROTEIN; PROTEIN BCL 2; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE 7; SMALL INTERFERING RNA; TROPHININ; UNCLASSIFIED DRUG; VIMENTIN;

ARTICLE; CANCER CELL CULTURE; CANCER CLASSIFICATION; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PREDICTION; PROTEIN EXPRESSION; PROTEIN TARGETING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ZYMOGRAPHY;

CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; ELECTRON TRANSPORT COMPLEX IV; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA INTERFERENCE;

EID: 84862980395     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-273     Document Type: Article

References (37)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90. 10.3322/caac.20107, 21296855.
2. Farray D, Mirkovic N, Albain KS. Multimodality therapy for stage III non-small-cell lung cancer. J Clin Oncol 2005, 23:3257-3269. 10.1200/JCO.2005.03.008, 15886313.
3. Reed MF, Molloy M, Dalton EL, Howington JA. Survival after resection for lung cancer is the outcome that matters. Am J Surg 2004, 188:598-602. 10.1016/j.amjsurg.2004.07.037, 15546578.
4. Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH. Eastern Cooperative Oncology Group: Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002, 346:92-98. 10.1056/NEJMoa011954, 11784875.
5. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000, 355:479-485.
6. Martini N, Bains MS, Burt ME, Zakowski MF, McCormack P, Rusch VW, Ginsberg RJ. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-129. 10.1016/S0022-5223(95)70427-2, 7815787.
7. Kawachi R, Tsukada H, Nakazato Y, Takei H, Furuyashiki G, Koshi-ishi Y, Goya T. Early recurrence after surgical resection in patients with pathological stage I non-small cell lung cancer. Thorac Cardiovasc Surg 2009, 57:472-475.
8. Hung JJ, Hsu WH, Hsieh CC, Huang BS, Huang MH, Liu JS, Wu YC. Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence. Thorax 2009, 64:192-196. 10.1136/thx.2007.094912, 19252018.
9. Steeg PS. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 2006, 12:895-904. 10.1038/nm1469, 16892035.
10. Wong SC, Chan CM, Ma BB, Lam MY, Choi GC, Au TC, Chan AS, Chan AT. Advanced proteomic technologies for cancer biomarker discovery. Expert Rev Proteomics 2009, 6:123-134. 10.1586/epr.09.1, 19385940.
11. Chen G, Gharib TG, Wang H, Huang CC, Kuick R, Thomas DG, Shedden KA, Misek DE, Taylor JM, Giordano TJ, Kardia SL, Iannettoni MD, Yee J, Hogg PJ, Orringer MB, Hanash SM, Beer DG. Protein profiles associated with survival in lung adenocarcinoma. Proc Natl Acad Sci U S A 2003, 100:13537-13542. 10.1073/pnas.2233850100, 263849, 14573703.
12. Tian T, Hao J, Xu A, Hao J, Luo C, Liu C, Huang L, Xiao X, He D. Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 2007, 98:1265-1274. 10.1111/j.1349-7006.2007.00514.x, 17537172.
13. Soel SM, Choi OS, Bang MH, Yoon Park JH, Kim WK. Influence of conjugated linoleic acid isomers on the metastasis of colon cancer cells in vitro and in vivo. J Nutr Biochem 2007, 10:650-657.
14. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, Wu R, Wu CW. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 1997, 17:353-360.
15. Chen WL, Liu WT, Yang MC, Hwang MT, Tsao JH, Mao SJ. A novel conformation-dependent monoclonal antibody specific to the native structure of beta-lactoglobulin and its application. J Dairy Sci 2006, 89:912-921. 10.3168/jds.S0022-0302(06)72156-7, 16507685.
16. Jovanović M, Stefanoska I, Radojcić L, Vićovac L. Interleukin-8 (CXCL8) stimulates trophoblast cell migration and invasion by increasing levels of matrix metalloproteinase (MMP)2 and MMP9 and integrins alpha5 and beta1. Reproduction 2010, 139:789-798. 10.1530/REP-09-0341, 20133364.
17. Hung WC, Tseng WL, Shiea J, Chang HC. Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. Cancer Lett 2010, 288:156-161. 10.1016/j.canlet.2009.06.032, 19625121.
18. Kuo KT, Wang HW, Chou TY, Hsu WH, Hsu HS, Lin CH, Wang LS. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma. Ann Surg Oncol 2009, 16:352-360. 10.1245/s10434-008-0242-2, 19050969.
19. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997, 275:1129-1132. 10.1126/science.275.5303.1129, 9027314.
20. Manon S, Chaudhuri B, Guérin M. Release of cytochrome c and decrease of cytochrome c oxidase in Bax-expressing yeast cells, and prevention of these effects by coexpression of Bcl-xL. FEBS Lett 1997, 415:29-32. 10.1016/S0014-5793(97)01087-9, 9326363.
21. Oyama T, Osaki T, Baba T, Nagata Y, Mizukami M, So T, Nakata S, Ichiki Y, Uramoto H, Sugaya M, Yoshimatsu T, Morita M, Hanagiri T, Sugio K, Kawamoto T, Yasumoto K. Molecular genetic tumor markers in non-small cell lung cancer. Anticaner Res 2005, 25:1193-1196.
22. Massion PP, Carbone DP. The molecular basis of lung cancer: molecular abnormalities and therapeutic implications. Respir Res 2003, 4:12. 10.1186/1465-9921-4-12, 314397, 14641911.
23. Johnson DH, Fehrenbacher L, Novotny WF, Herbst RS, Nemunaitis JJ, Jablons DM, Langer CJ, DeVore RF, Gaudreault J, Damico LA, Holmgren E, Kabbinavar F. Randomized phase II Trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004, 22:2184-2191. 10.1200/JCO.2004.11.022, 15169807.
24. Sandler A, Gray R, Perry MC, Brahmer J, Schiller JH, Dowlati A, Lilenbaum R, Johnson DH. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006, 355:2542-2550. 10.1056/NEJMoa061884, 17167137.
25. Reck M, von Pawel J, Zatloukal P, Ramlau R, Gorbounova V, Hirsh V, Leighl N, Mezger J, Archer V, Moore N, Manegold C. Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil. J Clin Oncol 2009, 27:1227-1234. 10.1200/JCO.2007.14.5466, 19188680.
26. Littlepage LE, Sternlicht MD, Rougier N, Phillips J, Gallo E, Yu Y, Williams K, Brenot A, Gordon JI, Werb Z. Matrix metalloproteinases contribute distinct roles in neuroendocrine prostate carcinogenesis, metastasis, and angiogenesis progression. Cancer Res 2010, 70:2224-2234. 10.1158/0008-5472.CAN-09-3515, 2840052, 20215503.
27. Park JK, Park SH, So K, Bae IH, Yoo YD, Um HD. ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int J Oncol 2010, 36:181-192.
28. Merkle M, Ribeiro A, Sauter M, Ladurner R, Mussack T, Sitter T, Wörnle M. Effect of activation of viral receptors on the gelatinases MMP-2 and MMP-9 in human mesothelial cells. Matrix Biol 2010, 29:202-208. 10.1016/j.matbio.2009.12.002, 20026404.
29. Fornuskova D, Stiburek L, Wenchich L, Vinsova K, Hansikova H, Zeman J. Novel insights into the assembly and function of human nuclear-encoded cytochrome c oxidase subunits 4, 5a, 6a, 7a and 7b. Biochem J 2010, 428:363-374. 10.1042/BJ20091714, 20307258.
30. Lenka N, Vijayasarathy C, Mullick J, Avadhani NG. Structural organization and transcription regulation of nuclear genes encoding the mammalian cytochrome c oxidase complex. Prog Nucleic Acid Res Mol Biol 1998, 61:309-344.
31. Ludwig B, Bender E, Arnold S, Hüttemann M, Lee I, Kadenbach B. Cytochrome C oxidase and the regulation of oxidative phosphorylation. Chembiochem 2001, 2:392-403. 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.0.CO;2-N, 11828469.
32. Brzezinski P, Johansson AL. Variable proton-pumping stoichiometry in structural variants of cytochrome c oxidase. Biochim Biophys Acta 2010, 1797:710-723. 10.1016/j.bbabio.2010.02.020, 20184858.
33. Chen ZX, Pervaiz S. Bcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells. Cell Death Differ 2007, 14:1617-1627. 10.1038/sj.cdd.4402165, 17510660.
34. Chen ZX, Pervaiz S. Involvement of cytochrome c oxidase subunits Va and Vb in the regulation of cancer cell metabolism by Bcl-2. Cell Death Differ 2010, 17:408-420. 10.1038/cdd.2009.132, 19834492.
35. Choi J, Choi K, Benveniste EN, Rho SB, Hong YS, Lee JH, Kim J, Park K. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res 2005, 65:5554-5560. 10.1158/0008-5472.CAN-04-4570, 15994927.
36. Noujaim D, van Golen CM, van Golen KL, Grauman A, Feldman EL. N-Myc and Bcl-2 coexpression induces MMP-2 secretion and activation in human neuroblastoma cells. Oncogene 2002, 21:4549-4557. 10.1038/sj.onc.1205552, 12085233.
37. Nieto N, Rojkind M. Repeated whiskey binges promote liver injury in rats fed a choline-deficient diet. J Hepatol 2007, 46:330-339. 2562542, 17156887.